Isolation and characterisation of a phenolic impurity in a commercial sample of duloxetine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 4, 2007, Pages 1573-1575

  Brenna, Elisabetta ^a   Frigoli, Samuele ^a   Fronza, Giovanni ^a   Fuganti, Claudio ^a   Malpezzi, Luciana ^a  

^a CNR   (Italy)

Author keywords

Duloxetine; Impurity; Isolation; Mitsunobu; Structural characterisation

Indexed keywords

[3 (4 HYDROXYNAPHTHALEN 1 YL) N METHYL 3 (THIOPHEN 2 YL)PROPAN 1 AMINIUM CHLORIDE]; DULOXETINE; NAPHTHALENE DERIVATIVE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG IMPURITY; DRUG ISOLATION; DRUG STRUCTURE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; X RAY ANALYSIS;

DRUG CONTAMINATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; PHENOL; SEROTONIN UPTAKE INHIBITORS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THIOPHENES;

EID: 33847182095     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.11.026     Document Type: Article

References (7)

1. Other studies on duloxetine impurities:
2. Jansen P.J., Oren P.L., Kemp C.A., Maple S.R., and Baertschi S.W. J. Pharm. Sci. 87 (1998) 81-85
3. Olsen B.A., and Argentine M.D. J. Liq. Chromatogr. Related Technol. 19 (1996) 1993-2007
4. Altomare A., Burla M.C., Camalli M., Cascarano G.L., Giacovazzo C., Guagliardi A., Moliteni A.G.G., Polidori G.P., and Spagna R. J. Appl. Crystallogr. 32 (1999) 115-119
5. Sheldrick G.M. SHELXL97. Release 97-2. Program for the Refinement of Crystal Structures (1997), University of Göttingen, Germany
6. Wheeler W.J., and Kuo F. J. Labelled Compd. Radiopharm. 36 (1995) 213-224
7. Galindo F. J. Photochem. Photobiol. C: Photochem. Rev. 6 (2005) 123-128